Dual versus triple therapy for atrial fibrillation after percutaneous coronary intervention: a systematic review and meta-analysis
Background: The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC]
plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 …
plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 …
Meta-analysis comparing the safety and efficacy of dual versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary …
I Cavallari, G Patti - The American journal of cardiology, 2018 - Elsevier
In patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI), the
effectiveness and safety of dual compared with triple antithrombotic therapy are a matter of …
effectiveness and safety of dual compared with triple antithrombotic therapy are a matter of …
[HTML][HTML] Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention
Y Saito, Y Kobayashi - Journal of Cardiology, 2019 - Elsevier
In patients with atrial fibrillation (AF), concomitant coronary artery disease is often present,
and vice versa. Optimal antithrombotic treatment for patients with AF undergoing …
and vice versa. Optimal antithrombotic treatment for patients with AF undergoing …
Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials
G Ando, F Costa - International Journal of Cardiology, 2020 - Elsevier
Aims Double or triple antithrombotic therapy (DAT/TAT) including or excluding aspirin in
association with oral anticoagulant and P2Y12 inhibitor are currently two available options …
association with oral anticoagulant and P2Y12 inhibitor are currently two available options …
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis
PM Haller, P Sulzgruber, C Kaufmann… - European Heart …, 2019 - academic.oup.com
Aims The combination of oral anticoagulation with a P2Y12 inhibitor and aspirin in patients
with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) is …
with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) is …
Safety and efficacy of double antithrombotic therapy with non–vitamin k antagonist oral anticoagulants in patients with atrial fibrillation undergoing percutaneous …
Background The optimal antithrombotic therapy for patients with atrial fibrillation undergoing
percutaneous coronary intervention is a topic of debate. We aimed at defining the efficacy …
percutaneous coronary intervention is a topic of debate. We aimed at defining the efficacy …
Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary …
TS Potpara, N Mujovic, M Proietti, N Dagres… - EP …, 2020 - academic.oup.com
Aims Recently, three randomized trials reported that dual antithrombotic treatments (DATs)
including non-vitamin K antagonist oral anticoagulants (NOACs) and a P2Y12 inhibitor …
including non-vitamin K antagonist oral anticoagulants (NOACs) and a P2Y12 inhibitor …
Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic …
G Gargiulo, A Goette, J Tijssen, L Eckardt… - European heart …, 2019 - academic.oup.com
Aims To investigate the safety and efficacy of double vs. triple antithrombotic therapy (DAT
vs. TAT) in patients with atrial fibrillation (AF) and acute coronary syndrome or who …
vs. TAT) in patients with atrial fibrillation (AF) and acute coronary syndrome or who …
Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective …
A growing number of patients undergoing percutaneous coronary intervention (PCI) with
stent implantation also have atrial fibrillation. This poses challenges for their optimal …
stent implantation also have atrial fibrillation. This poses challenges for their optimal …
Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous …
Aims Safety and efficacy of antithrombotic regimens in patients with atrial fibrillation (AF)
undergoing percutaneous coronary intervention (PCI) may differ based on clinical …
undergoing percutaneous coronary intervention (PCI) may differ based on clinical …